Literature DB >> 16228202

Presence of glucosylceramide in yeast and its relation to alkali tolerance of yeast.

Katsuichi Saito1, Naoya Takakuwa, Masao Ohnishi, Yuji Oda.   

Abstract

Glycosylceramide is a membrane lipid that has physiological functions in eukaryotic organisms. The presence of glucosylceramide has been confirmed in some yeast; however, the extent of the role of glucosylceramide in yeast is unknown. Thus, the extent of presence of glucosylceramide in yeast was surveyed using 90 strains of 24 genera. The strains were divided into two groups according to whether they had glucosylceramide (45 strains) or not (45 strains). The distribution of the ceramide glucosyltransferase gene (EC 2.4.1.80), which catalyzes glucosylation to a sphingoid lipid in glucosylceramide synthesis, and the phylogenetic classification of the strains were in agreement with those of glucosylceramide. Thus, the presence of glucosylceramide in yeast was caused by the presence of the gene involved in glucosylceramide synthesis and was closely associated with yeast evolution. Furthermore, the relationship between glucosylceramide presence and alkali tolerance of yeast was evaluated. The yeast with glucosylceramide tended to grow at higher pH, and a ceramide-glucosyltransferase-defective mutant from Kluyveromyces lactis did not grow at pH 8.5 even though the parent strain could grow under the same conditions. These results indicate that glucosylceramide in yeast might be a component that enables yeast to grow under alkali conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16228202     DOI: 10.1007/s00253-005-0187-3

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  31 in total

1.  Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1).

Authors:  Yohei Ishibashi; Kazutaka Ikeda; Keishi Sakaguchi; Nozomu Okino; Ryo Taguchi; Makoto Ito
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

Review 2.  Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.

Authors:  Ryan Rhome; Travis McQuiston; Talar Kechichian; Alicja Bielawska; Mirko Hennig; Monica Drago; Giulia Morace; Chiara Luberto; Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2007-08-10

3.  Reconstitution of glucosylceramide flip-flop across endoplasmic reticulum: implications for mechanism of glycosphingolipid biosynthesis.

Authors:  Madhavan Chalat; Indu Menon; Zeynep Turan; Anant K Menon
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

4.  Functional characterization of the Aspergillus nidulans glucosylceramide pathway reveals that LCB Δ8-desaturation and C9-methylation are relevant to filamentous growth, lipid raft localization and Psd1 defensin activity.

Authors:  C M Fernandes; P A de Castro; A Singh; F L Fonseca; M D Pereira; T V M Vila; G C Atella; S Rozental; M Savoldi; M Del Poeta; G H Goldman; E Kurtenbach
Journal:  Mol Microbiol       Date:  2016-08-25       Impact factor: 3.501

5.  Vesicular Trans-Cell Wall Transport in Fungi: A Mechanism for the Delivery of Virulence-Associated Macromolecules?

Authors:  Marcio L Rodrigues; Leonardo Nimrichter; Debora L Oliveira; Joshua D Nosanchuk; Arturo Casadevall
Journal:  Lipid Insights       Date:  2008-08

6.  Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.

Authors:  Arpita Singh; Haitao Wang; Liana C Silva; Chongzheng Na; Manuel Prieto; Anthony H Futerman; Chiara Luberto; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2012-01-09       Impact factor: 3.715

7.  Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.

Authors:  Philipp C Rittershaus; Talar B Kechichian; Jeremy C Allegood; Alfred H Merrill; Mirko Hennig; Chiara Luberto; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

8.  In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis.

Authors:  Patricia M Tavares; Karin Thevissen; Bruno P A Cammue; Isabelle E J A François; Eliana Barreto-Bergter; Carlos P Taborda; Alexandre F Marques; Marcio L Rodrigues; Leonardo Nimrichter
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

Review 9.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

10.  Glycolipid transfer protein expression is affected by glycosphingolipid synthesis.

Authors:  Matti A Kjellberg; Peter Mattjus
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.